Assembly and Folding Properties of Cytosolic IgG Intrabodies
暂无分享,去创建一个
[1] T. Boldicke. Single domain antibodies for the knockdown of cytosolic and nuclear proteins. , 2017 .
[2] T. Böldicke. Single domain antibodies for the knockdown of cytosolic and nuclear proteins , 2017, Protein science : a publication of the Protein Society.
[3] S. Dübel,et al. Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? , 2016, Computational and structural biotechnology journal.
[4] J. Riemer,et al. Balancing oxidative protein folding: the influences of reducing pathways on disulfide bond formation. , 2014, Biochimica et biophysica acta.
[5] G. Vidarsson,et al. Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange , 2014, The Journal of Biological Chemistry.
[6] U. Jakob,et al. Oxidant Sensing by Reversible Disulfide Bond Formation* , 2013, The Journal of Biological Chemistry.
[7] M. Matsumura,et al. The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress. , 2013, Journal of pharmaceutical sciences.
[8] B. Stockwell,et al. Protein Folding Drives Disulfide Formation , 2012, Cell.
[9] Max Tejada,et al. Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. , 2012, Analytical chemistry.
[10] Hongcheng Liu,et al. Disulfide bond structures of IgG molecules , 2012, mAbs.
[11] É. Margittai,et al. Oxidative Protein Folding in the Secretory Pathway and Redox Signaling Across Compartments and Cells , 2011, Traffic.
[12] Douglas S Rehder,et al. Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding. , 2010, Biochemistry.
[13] Sun-Gu Lee,et al. Redesigning of anti‐c‐Met single chain Fv antibody for the cytoplasmic folding and its structural analysis , 2010, Biotechnology and bioengineering.
[14] M. Sierks,et al. Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm. , 2010, Protein engineering, design & selection : PEDS.
[15] Hongcheng Liu,et al. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. , 2010, Analytical chemistry.
[16] D. Ouellette,et al. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule. , 2010, Analytical biochemistry.
[17] J. Laurence,et al. The role of thiols and disulfides on protein stability. , 2009, Current protein & peptide science.
[18] Lesley N. Weaver,et al. Kinesin-14 family proteins HSET/XCTK2 control spindle length by cross-linking and sliding microtubules. , 2009, Molecular biology of the cell.
[19] Dean P. Jones,et al. Redox compartmentalization in eukaryotic cells. , 2008, Biochimica et biophysica acta.
[20] T. Rabbitts,et al. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. , 2008, Journal of molecular biology.
[21] M. Matsumura,et al. Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain , 2007, Protein science : a publication of the Protein Society.
[22] J. Beckwith. What Lies Beyond Uranus?: Preconceptions, Ignorance, Serendipity and Suppressors in the Search for Biology's Secrets , 2007, Genetics.
[23] N. M. Gevondyan,et al. Four free cysteine residues found in human IgG1 of healthy donors , 2006, Biochemistry (Moscow).
[24] Dean P. Jones,et al. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. , 2006, Annual review of pharmacology and toxicology.
[25] A. Holmgren,et al. Thiol redox control via thioredoxin and glutaredoxin systems. , 2005, Biochemical Society transactions.
[26] A. Messer,et al. Intrabody applications in neurological disorders: progress and future prospects. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] D. Röthlisberger,et al. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. , 2005, Journal of molecular biology.
[28] M. Quondam,et al. The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation. , 2004, Methods.
[29] Jason C. Young,et al. Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.
[30] Ursula Jakob,et al. Not every disulfide lasts forever: disulfide bond formation as a redox switch. , 2003, Antioxidants & redox signaling.
[31] C. Barbas,et al. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor , 2003, Oncogene.
[32] A. Schots,et al. Formation of Disulfide Bridges by a Single-chain Fv Antibody in the Reducing Ectopic Environment of the Plant Cytosol* , 2002, The Journal of Biological Chemistry.
[33] Sun Park,et al. PRODUCTION AND CHARACTERIZATION OF AN ANTI-IDIOTYPIC SINGLE CHAIN FV THAT RECOGNIZES AN ANTI-DNA ANTIBODY , 2002, Immunological investigations.
[34] S. Schillberg,et al. Apoplastic and cytosolic expression of full‐size antibodies and antibody fragments in Nicotiana tabacum , 1999, Transgenic Research.
[35] P. Carter,et al. Contribution of domain interface residues to the stability of antibody CH3 domain homodimers. , 1998, Biochemistry.
[36] A. Plückthun,et al. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly , 1998, FEBS letters.
[37] O. Cochet,et al. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. , 1998, Cancer research.
[38] A. Plückthun,et al. Antibody scFv fragments without disulfide bonds made by molecular evolution. , 1998, Journal of molecular biology.
[39] A. Cattaneo,et al. Redox State of Single Chain Fv Fragments Targeted to the Endoplasmic Reticulum, Cytosol and Mitochondria , 1995, Bio/Technology.
[40] X. Montano,et al. Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[41] A. Cattaneo,et al. Intracellular Immunization with Cytosolic Recombinant Antibodies , 1994, Bio/Technology.
[42] A. Cattaneo,et al. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack , 1993, Nature.
[43] R. Glockshuber,et al. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. , 1992, Biochemistry.
[44] D. Hilvert,et al. In vivo catalysis of a metabolically essential reaction by an antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Neuberger,et al. Expression and targeting of intracellular antibodies in mammalian cells. , 1990, The EMBO journal.
[46] C. Chang,et al. Analysis of immunoglobulin domain interactions. Evidence for a dominant role of salt bridges. , 1988, Journal of molecular biology.
[47] J. Carlson,et al. A new means of inducibly inactivating a cellular protein , 1988, Molecular and cellular biology.
[48] R J Harris,et al. Heterogeneity of recombinant antibodies: linking structure to function. , 2005, Developments in biologicals.
[49] P. Saviranta,et al. Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions. , 2005, Journal of immunological methods.
[50] Wei Zhang,et al. Free Sulfhydryl in Recombinant Monoclonal Antibodies , 2002, Biotechnology progress.
[51] J. Schell,et al. Self assembly of immunoglobulins in the cytoplasm of the alga Acetabularia mediterranea , 1991 .